CytomX Therapeutics Announces Proposed Public Offering of Common Stock

Relay Therapeutics Names Steven Kafka To Its Board of Directors

Zafgen and the Foundation for Prader-Willi Research Announce PATH for PWS Natural History Study

Roche commences tender offer for all shares of Foundation Medicine, Inc. for US$ 137.00 per share in cash

Zafgen Announces Closing of Offering of Common Stock and Exercise in Full of the Underwriters’ Option to Purchase Additional Common Shares